Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Covington
Johnson and Johnson
UBS
Argus Health
Moodys
Baxter
Citi

Generated: August 21, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ENOXAPARIN SODIUM

« Back to Dashboard

ENOXAPARIN SODIUM

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC N 0075-0620-40
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC N 0075-0621-60
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC N 0075-0622-80
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC N 0075-0623-00
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC N 0075-0624-30
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC N 0075-0626-03
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC N 0075-2912-01
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Teva
Johnson and Johnson
AstraZeneca
Baxter
McKinsey
Federal Trade Commission
Accenture
Deloitte